- Home
- SIMO vs VRDN Comparison
SIMO vs VRDN Comparison
Compare SIMO & VRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SIMO | VRDN |
|---|---|---|
| Founded | 1995 | 2006 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 2.7B |
| IPO Year | 2005 | N/A |
Fundamental Metrics
Financial Performance| Metric | SIMO | VRDN |
|---|---|---|
| Price | $105.00 | $30.77 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 12 |
| Target Price | ★ $103.13 | $40.45 |
| AVG Volume (30 Days) | 257.6K | ★ 1.4M |
| Earning Date | 02-04-2026 | 11-05-2025 |
| Dividend Yield | ★ 2.14% | N/A |
| EPS Growth | ★ 8.75 | N/A |
| EPS | ★ 2.87 | N/A |
| Revenue | ★ $798,326,000.00 | $70,789,000.00 |
| Revenue This Year | $10.15 | $26,257.62 |
| Revenue Next Year | $17.72 | $10.69 |
| P/E Ratio | $32.61 | ★ N/A |
| Revenue Growth | N/A | ★ 23340.07 |
| 52 Week Low | $37.21 | $9.90 |
| 52 Week High | $106.60 | $34.04 |
Technical Indicators
Market Signals| Indicator | SIMO | VRDN |
|---|---|---|
| Relative Strength Index (RSI) | 74.20 | 48.43 |
| Support Level | $88.31 | $28.96 |
| Resistance Level | $90.73 | $31.54 |
| Average True Range (ATR) | 3.56 | 1.07 |
| MACD | 1.37 | -0.43 |
| Stochastic Oscillator | 87.81 | 39.58 |
Price Performance
Historical ComparisonAbout SIMO Silicon Motion Technology Corporation
Silicon Motion Technology Corp is engaged in developing NAND flash controllers for SSDs and other solid state storage devices. Its only operating segment is to develop NAND flash controllers and SSDs solutions. The company derives revenue from product categories such as Mobile Storage, Mobile Communications, and others. Silicon's geographical segments are Taiwan, the United States, Korea, China, Singapore, Malaysia, and others. The company products are used in Personal Computing, Smartphone/Tablet/CE, Flash Card/USB Flash Drive, Industrial and Embedded, Automotive, and Enterprise and Data centers.
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).